Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
Colony Capital, Inc. (CLNY)
|
Add to portfolio |
|
|
|
| Price: |
$6.69
| | Metrics |
| OS: |
113.4
|
M
| |
2
|
% ROE
|
| Market cap: |
$759
|
M
| |
-7
|
% ROIC
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
$0.85
| |
7.9
|
x P/E
|
|
BVPS
|
$49.77
| |
0.13
|
x P/B
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 07/24/2020 |
GN
| CLNY FINAL DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Colony Capital, Inc. Investors of Important July 27 Deadline in Securities Class Act...
|
| 07/22/2020 |
GN
| DEADLINE ALERT for CLNY, CCL, WFC, HEBT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders |
| 07/19/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Colony Capital, Inc. of Class Action Lawsuit and Upcoming ...
|
| 07/17/2020 |
GN
| ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Reminds Colony Capital, Inc. Investors of Important July 27 Deadline in Securities Class Action; Enc...
|
| 07/17/2020 |
GN
| CLNY Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Colony Capital, Inc. and Encourages Investors to Con...
|
| 07/15/2020 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Colony Capital, Sorrento Therapeutics, Carnival Corporat...
|
| 07/15/2020 |
GN
| DEADLINE ALERT for CLNY, CCL, and WFC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Jun-23-09 |
| Revenues | 332.5 | 213.5 | 82.3 | 108.0 | 65.5 | 27.4 | 0.0 |
| Revenue growth | 55.8% | 159.5% | -23.8% | 64.9% | 138.7% | | |
| Cost of goods sold | 237.1 | 163.9 | 48.3 | 30.2 | 14.3 | 4.5 | 0.7 |
| Gross profit | 95.4 | 49.6 | 34.0 | 77.8 | 51.2 | 22.9 | -0.7 |
| Gross margin | 28.7% | 23.2% | 41.3% | 72.0% | 78.2% | 83.4% | |
| General and administrative | 41.0 | 43.9 | 41.3 | 6.3 | 5.8 | 5.3 | 0.8 |
| EBIT | -52.6 | -75.9 | -45.5 | -3.1 | 11.9 | 11.2 | 0.7 |
| EBIT margin | -15.8% | -35.5% | -55.3% | -2.9% | 18.1% | 40.9% | |
| Pre-tax income | -60.3 | -81.1 | -47.1 | 70.4 | 44.6 | 18.0 | -0.4 |
| Income taxes | 0.8 | -0.7 | 0.7 | 2.2 | 1.2 | 0.2 | 0.0 |
| Tax rate | | 0.9% | | 3.1% | 2.7% | 1.4% | 0.0% |
| Net income | -61.1 | -80.5 | -47.7 | 48.1 | 42.3 | 17.7 | -0.4 |
| Net margin | -18.4% | -37.7% | -58.0% | 44.5% | 64.5% | 64.7% | |
| |
| Diluted EPS | | | | $1.34 | $1.46 | $1.18 | ($0.06) |
| Shares outstanding (diluted) | | | | 35.9 | 29.0 | 15.0 | 7.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|